BioPharma Dive 20 avr. 2026 Nektar surges again as alopecia drug shows new promise in extension study
BioPharma Dive 20 avr. 2026 AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
BioPharma Dive 20 avr. 2026 [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services
BioPharma Dive 17 avr. 2026 Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
BioPharma Dive 16 avr. 2026 Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director
BioPharma Dive 15 avr. 2026 Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers